Next report date
Report period
Q1 2024
EPS estimate
−0.39USD
Revenue estimate
2.35 MUSD
−4.33USD
−2.17 MUSD
7.14 MUSD
4.87 M
About CervoMed Inc.
Sector
CEO
John J. Alam
Website
Headquarters
Boston
Employees (FY)
8
Founded
1995
FIGI
BBG000N6JH48
CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of CRVO is 23.82 USD — it has decreased by 4.68% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange CervoMed Inc. stocks are traded under the ticker CRVO.
CervoMed Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
CRVO stock is 7.05% volatile and has beta coefficient of 0.35. Check out the list of the most volatile stocks — is CervoMed Inc. there?
CRVO earnings for the last quarter are −0.70 USD per share, whereas the estimation was −0.95 USD resulting in a 26.32% surprise. The estimated earnings for the next quarter are −0.62 USD per share. See more details about CervoMed Inc. earnings.
Yes, you can track CervoMed Inc. financials in yearly and quarterly reports right on TradingView.
CRVO stock has fallen by 6.15% compared to the previous week, the month change is a 16.20% rise, over the last year CervoMed Inc. has showed a 309.61% increase.
CRVO net income for the last quarter is −2.36 M USD, while the quarter before that showed 2.15 M USD of net income which accounts for −209.86% change. Track more CervoMed Inc. financial stats to get the full picture.
Today CervoMed Inc. has the market capitalization of 196.60 M, it has decreased by 3.86% over the last week.
No, CRVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CRVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CervoMed Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 8.00 employees. See our rating of the largest employees — is CervoMed Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CervoMed Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CervoMed Inc. stock shows the neutral signal. See more of CervoMed Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on CervoMed Inc. future price: according to them, CRVO price has a max estimate of 65.00 USD and a min estimate of 30.00 USD. Read a more detailed CervoMed Inc. forecast: see what analysts think of CervoMed Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CervoMed Inc. EBITDA is −11.71 M USD, and current EBITDA margin is −109.35%. See more stats in CervoMed Inc. financial statements.